Erratum: Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents (Journal of Medicinal Chemistry (2012) 55 (6381-6390) DOI: 10.1021/jm300644g);Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents

Journal of Medicinal Chemistry

Volumn 55, Issue 14, 2012, Pages 6381-6390

  Singh, Palwinder ^a   Kaur, Matinder ^a   Sachdeva, Shaveta ^a  

^a GURU NANAK DEV UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,6 DICHLOROPHENYL) 3 (4 HYDROXY 3,5 DIMETHOXYBENZYLIDENE) 1,3 DIHYDROINDOL 2 ONE; 3 (4 HYDROXY 3,5 DIMETHOXYBENZYLIDENE) 1,3 DIHYDROINDOL 2 ONE; ANTINEOPLASTIC AGENT; BENZYLIDENE DERIVATIVE; DIHYDROFOLATE REDUCTASE; DIHYDROFOLATE REDUCTASE INHIBITOR; DIHYDROFOLIC ACID; INDOLE DERIVATIVE; INDOMETACIN; METHOTREXATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SYRINGALDEHYDE DERIVATIVE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DESIGN; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; ENZYME MECHANISM; HUMAN; HUMAN CELL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; ULTRAVIOLET SPECTROSCOPY;

EID: 84864220261     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4000424     Document Type: Erratum

References (26)

1. Groff, J. P. A Structure-Function Study of Dihydrofolate Reductase: The Role of Tryptophan Residues. Ph.D. Thesis, University of Iowa, 1980.
2. Roth, B. A.; Falco, E. A.; Hitchings, G. H.; Bushby, R. M. 5-Benzyl-2,4-diaminopyrimidines as Antibacterial Agents.1.Synthesis and Antibacterial Activity in Vitro J. Med. Pharm. Chem. 1962, 5, 1103-1123
3. Carl, W. S.; Michael, E. G.; Charles, A. N. Metabolism of Trimethoprim in Man and Measurement of a New Metabolite: A New Fluorescence Assay J. Infect. Dis. 1973, 128, S580-S583
4. Heidelberger, C.; Chaudhuri, N. K.; Danneberg, P.; Mooren, D.; Griesbach, L.; Duschinsky, K.; Schnitzer, R.; Pleven, E.; Scheiner, J. Fluorinated Pyrimidines, a New Class of Tumour Inhibitory Compounds Nature 1957, 179, 663-666
5. Anticancer activity of 5-fluorouracil available in NCI data base (www.dtp.nci.nih.gov), NSC 19893.
6. Anticancer activity of methotrexate available in NCI data base (www.dtp.nci.nih.gov), NSC 740.
7. Chabner, B. A. Methotrexate. In Clinical Pharmacology of Antineoplastic Agents; Chabner, B. A., Ed.; W. B. Saunders: Philadelphia, PA, 1982.
8. Jolivet, J.; Schilsky, R. L.; Bailey, B. D.; Drake, J. C.; Chabner, B. A. Synthesis, Retention and Biological Activity of Methotrexate Polyglutamates in Cultured Human Breast Cancer Cells J. Clin. Invest. 1982, 70, 351-360
9. Li, R.; Sirawaraporn, R.; Chitnumsub, P.; Sirawaraporn, W.; Wooden, J.; Athappilly, F.; Turley, S.; Hol, W. G. J. Three-Dimensional Structure of M. tuberculosis Dihydrofolate Reductase Reveals Opportunities for the Design of Novel Tuberculosis Drugs J. Mol. Biol. 2000, 295, 307-323
10. Oefner, C.; Bandera, M.; Haldimann, A.; Laue, H.; Schulz, H.; Mukhija, S.; Parisi, S.; Weiss, L.; Lociuro, S.; Dale, G. E. Increased Hydrophobic Interactions of Iclaprim with Staphylococcus aureus Dihydrofolate Reductase Are Responsible for the Increase in Affinity and Antibacterial Activity J. Antimicrob. Chemother. 2009, 63, 687-698
11. Heaslet, H.; Harris, M.; Fahnoe, K.; Sarver, R.; Putz, H.; Chang, J.; Subramanyam, C.; Barreiro, G.; Miller, J. R. Structural Comparison of Chromosomal and Exogenous Dihydrofolate Reductase from Staphylococcus aureus in Complex with the Potent Inhibitor Trimethoprim Proteins 2009, 76, 706-717
12. Donkor, I. O.; Li, H.; Queener, S. F. Synthesis and DHFR Inhibitory Activity of a Series of 6-Substituted-2,4-diaminothieno[2,3- d ]pyrimidines Eur. J. Med. Chem. 2003, 38, 605-611
13. Gangjee, A.; Vidwans, A.; Elzein, E.; McGuire, J. J.; Queener, S. F.; Kisliuk, R. L. Synthesis, Antifolate and Antitumour Activities of Classical and Nonclassical 2-Amino-4-oxo-5-substituted-pyrrolo[2,3- d ]pyrimidines J. Med. Chem. 2001, 44, 1993-2003
14. Wyss, P. C.; Gerber, P.; Hartman, P. G.; Hubschwerlen, C.; Locher, H.; Marty, H. P.; Stahl, M. Novel Dihydrofolate Reductase Inhibitors. Structure-Based versus Diversity-Based Library Design and High-Throughput Synthesis and Screening J. Med. Chem. 2003, 46, 2304-2312
15. Gangjee, A.; Qiu, Y.; Li, W.; Kisliuk, R. L. Potent Dual Thymidylate Synthase and Dihydrofolate Reductase Inhibitors: Classical and Nonclasssical 2-Amino-4-oxo-5-arylthio-substituted-6-methylthieno[2,3- d ]pyrimidine Antifolates J. Med. Chem. 2008, 51, 5789-5797
16. Rosowsky, A.; Fu, H.; Chan, D. C. M.; Queener, S. F. Synthesis of 2,4-Diamino-6-[2′- O -(ω-carboxyalkyl)oxydibenz[ b, f ]azepin-5-yl]-methylpteridines as Potent and Selective Inhibitors of Pneumocystis carnii, Toxoplasma gondii, and Mycobacterium avium Dihydrofolate Reductase J. Med. Chem. 2004, 47, 2475-2485
17. Gangjee, A.; Li, W.; Kisliuk, R.; Cody, V.; Pace, J.; Piraino, J.; Makin, J. Design, Synthesis and X-ray Crystal Structure of Classical and Nonclassical 2-Amino-4-oxo-5-substituted-pyrrolo[2,3- d ]pyrimidines as Dual Thymidylate Synthase and Dihydrofolate Reductase Inhibitors and as Potential Antitumour Agents J. Med. Chem. 2009, 52, 4892-4902
18. Li, X.; Hilgers, M.; Cunningham, M.; Chen, Z.; Trzoss, M.; Zhang, J.; Kohnen, L.; Lam, T.; Creighton, C.; Kedar, G. C.; Nelson, K.; Kwan, B.; Stidham, M.; Brown-Driver, M.; Shaw, K. J.; Finn, J. Structure Based Design of New DHFR-Based Antibacterial Agents: 7-Aryl-2,4-diaminoquinazolines Bioorg. Med. Chem. Lett. 2011, 21, 5171-5176
19. Schneider, P.; Hawser, S.; Islam, K. Iclaprim, a Novel Diamino Pyrimidine with Potant Activity on Trimethoprim Sensitive and Resistant Bacteria Bioorg. Med. Chem. Lett. 2003, 13, 4217-4221
20. Rees, R. W. A.; Chai, S. Y.; Winkley, M. W.; Russel, P. B. Antimalarial Activity of Some Novel Derivatives of 2,4-Diamino-(5- p -chlorophenyl)-6- ethylpyrimidine (Pyrimethamine) J. Med. Chem. 1976, 19 (5) 723-725
21. Then, R. L.; Hermann, F. Properties of Brodimoprim as an Inhibitor of Dihydrofolate Reductases Chemotherapy 1984, 30 (1) 18-25
22. Lai, W. G.; Zahid, N.; Uetrecht, J. P. Metabolism of Trimethoprim to a Reactive Iminioquinone Methide by Activated Human Neutrophils and Hepatic Microsomes J. Pharmacol. Expt. Ther 1999, 291, 292-299
23. Developmental Therapeutics Program, NCI/NIH. www.dtp.nci.nih.gov.
24. Anticancer activity of indomethacin available in NCI data base (www.dtp.nci.nih.gov), NSC 77541.
25. -5 M.
26. Hildebrand, J. H.; Benesi, H. A. A Spectrophotometric Investigation of the Interaction of Iodine with Aromatic Hydrocarbons J. Am. Chem. Soc. 1949, 71, 2703-2707